1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2015-2020

Companion diagnostics is an in-vitro diagnostic tool that assists physicians in optimizing treatment decisions for their patients. The companion diagnostic is crucial for the safe and effective use of the drug and have been widely developed for myriad of cancer and other therapies. Each companion diagnostic test is specifically designed to be paired with a specific drug. Such tests can also save significant healthcare costs by targeting the patients with most effective therapy.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.

The market for Companion diagnostics is classified into several categories based on technology, applications and end users.

Polymerase Chain Reaction (PCR) is the biggest revenue generating segment by type of technology used.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

The prominent players profiled in this report are:
Abbott Laboratories
Advanced Cell Diagnostics Inc.
Agilent Technologies, Inc.
Biomérieux and Biogenex Laboratories.

The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Companion diagnostics Market during the forecast period 2015-2020.

Table Of Contents

Companion Diagnostics Market: By Technology (PCR, Polymerase Chain Reaction (PCR), ISH, IHC, Others) Applications (Breast Cancer, Lung Cancer, Gastric Cancer, Others) End Users (Pharmaceuticals, Laboratries, Research Institutes, Others)-Forecast(2015-2020
1. Companion Diagnostics Market - Market Overview
2. Executive Summary
3. Companion Diagnostics Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Companion Diagnostics Market - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Companion Diagnostics Market - Government Regulations
6. Companion Diagnostics Market - Strategic Analysis
6.1. Value Chain Analysis
6.2. Pricing Analysis
6.3. Opportunities Analysis
6.4. Product/Market Life Cycle Analysis
7. Companion Diagnostics Market - By Technology
7.1. Polymerase Chain Reaction (PCR)
7.2. Sequencing-based
7.3. In Situ Hybridization (ISH)
7.4. Immunohistochemistry (IHC)
7.5. Others
8. Companion Diagnostics Market - By Applications
8.1. Breast Cancer
8.2. Lung Cancer
8.3. Colorectal Cancer
8.4. Melanoma
8.5. Gastric Cancer
8.6. Others
9. Companion Diagnostics Market - By End Users
9.1. Pharmaceutical Companies
9.2. Reference Laboratries
9.3. CRO
9.4. Hospitals
9.5. Research Institutes
10. Companion Diagnostics Market - Geographic Analysis
10.1. Americas
10.2. Europe
10.3. APAC
10.4. ROW
11. Market Entropy
11.1. New Product Launches
11.2. MandAs, Collaborations, JVs and Partnerships
12. Company Profiles (Overview, Financials, SWOT Analysis - Top 5 Companies, Developments, Product Portfolio)
12.1. Abbott Laboratories
12.2. Advanced Cell Diagnostics Inc.
12.3. Agilent Technologies, Inc.
12.4. Biomerieux
12.5. Biogenex Laboratories
12.6. Danaher Corporation
12.7. GE Healthcare
12.8. Myriad Genetics, Inc.
12.9. Qiagen N.V.
12.10. Roche Diagnostics
12.11. Thermo Fisher Scientific, Inc.
12.12. R-Biopharm AG
12.13. Cypher Genomics
12.14. Flagship Biosciences
12.15. Applied Proteomics
12.16. Ignyta, Inc.
12.17. Madison Vaccines, Inc.
12.18. Ventana Medical Systems, Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
13. Appendix
13.1. Abbreviations
13.2. Sources
13.3. Research Methodology
13.4. Bibliography
13.5. Compilation of Expert Insights
13.6. Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

Cancer Diagnostics 2020: Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities--Tumor Markers, Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review,  Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

Tumor Markers: Supplier Shares by Test, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review, Emerging Opportunities--France, Germany, Italy, Japan, Spain, UK, US

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100.  The report is available by country, section, market segment, and can be custom-tailored to your specific ...

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Europe Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 12800
  • Industry report
  • August 2016
  • by Venture Planning Group

This unique report provides information not available from any other published source, including volume, sales, and leading supplier shares by test. This comprehensive five-country report identifies and ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.